ISODIOL INTERNATIONAL INC. ANNOUNCES LICENSING AGREEMENT WITH LIVECARE HEALTH CANADA INC. AND APPOINTS DR. AMIT MATHUR TO MEDICAL ADVISORY BOARD
Isodiol International Inc. has signed a licencing agreement with Livecare Health Canada Inc., an organization founded and operated by doctors dedicated to giving patients access to quality, real-time health care, regardless of where they are located.
Livecare is a Vancouver-based company committed to empowering health care through technology. Founded by Dr. Mark Godley in 2012, it offers digital technologies that connect doctors and allied health care providers to their patients via secure, encrypted, face-to-face video and messaging.
Under the terms of the licencing agreement, Isodiol will license the Telehealth platform and operate it under a white label in connection with the marketing of all its products. The licence shall grant Isodiol the exclusive right to use the platform relating to all cannabis, cannabis-derived, cannabinoid and phytoceutical products, and related services. Livecare will customize and convey the platform for Isodiol and will assist in marketing and commercializing the platform on a global scale.
The platform is generally described as an interconnectivity network with a cloud-based user interface that provides access by multiple categories of users, including patients, physicians, other medical professionals, pharmaceutical providers and on personal computing devices to deliver health and wellness solutions without regard to the physical location of the users.
"Isodiol is extremely proud of this innovative step, where our consumers will now have the ability to consult with medical experts via the Telehealth platform technology," said chief executive officer of Isodiol, Marcos Agramont. "Our customers are extremely valued and consumers around the globe, particularly in urban areas, will now face little to no inconveniences when seeking health and wellness improvement."
As a part of the licencing agreement, the company will pay Livecare a royalty dependant on the jurisdiction of commercialization. The company will also issue four quarterly installments of stock in the first year of $250,000 which will be subject to a 36-month escrow schedule.
In addition to the licencing agreement, Isodiol has appointed Dr. Amit Mathur, co-founder of Livecare, as a medical adviser to the company with focus on implementing a global strategy for the commercialization of the platform.
Over the years, Dr. Mathur has lectured on behalf and participated on national advisory boards to multiple pharmaceutical companies. He has a passion for rural healthcare and has participated in international conferences and seminars in Asia as an adviser and keynote speaker on rural eye health delivery. He bridges his health care and clinic operations experience with his business consulting background to be uniquely effective.
"We are excited to welcome Dr. Mathur to the Isodiol family and we are confident that he will be a valuable addition to the team," said Mr. Agramont. "Dr. Mathur will play a valuable role in ensuring communities and rural municipalities will receive greater access to physicians and allied health providers."
About Isodiol International Inc.
Isodiol International is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products. Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99 per cent plus pure, bioactive pharmaceutical grade cannabinoids, microencapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio, and aggressively continuing international expansion into Latin America, Asia and Europe.
We seek Safe Harbor.
© 2018 Canjex Publishing Ltd. All rights reserved.